What is Nucala?
Nucala (mepolizumab) is a prescribed, subcutaneous injection used to treat conditions associated with elevated eosinophils, a type of white blood cell involved in inflammation. It is approved for treating severe eosinophilic asthma in adults and children (6 years and older), eosinophilic granulomatosis with polyangiitis (EGPA), chronic rhinosinusitis with nasal polyps, and hypereosinophilic syndrome (HES) in specific age groups. Nucala works by targeting and reducing eosinophils to help control inflammation and symptoms of these conditions.